chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Low temperature fever; Tiredness; Cough; Muscle pain; Joint pain; Have loss of my appetite; Arm swelling; Chills; This is a spontaneous report from a contactable consumer (Patient himself). A 33-year-old male patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Solution for injection; Lot number: EL9265, Expiry date, NDC number, UPC number was not reported), via an unspecified route of administration on 08Apr2021 (Age at vaccination 33-year-old) as dose 1, single for COVID-19 immunisation. The patient medical history and concomitant medications were not reported. The patient experienced low temperature fever, tiredness, cough on 16Apr2021. The patient experienced chills, arm swelling, muscle pain, joint pain, have loss of him appetite on Apr2021. It has been eight days from the first shot, and he was still having low temperature fever and he cough a few times and he was tired a little bit. Consumer stated, he got his vaccination from Pfizer, last Thursday afternoon at around like 2:00 PM on 8April, he got the first shot from Pfizer vaccine (COVID Vaccine). After that, he developed, he had a low temperature fever, chills, tiredness, arm swelling and cough, muscle pain and joint pain. Also, he had loss of his appetite somewhere, he did not feel like itching or anything like that. So, he did not know because it had been eight days from the first shot, and he was still having low temperature fever and he cough a few times and he was tired a little bit. He did not know whether it was normal, and he want to know, how long it will take to get normal and what should he do. Consumer stated, he got it at a Pharmacy, it was a pharmacy. Consumer stated, he only had two pills of Tylenol. Therapeutic measures were taken for the events. The outcome of all the events was unknown.  No follow-up attempts are needed. No further information is expected.
Vaccine was given to patient. After 1 minute after administration, patient began experiencing chest pain. Patient took 1 NTG tablet and pain improved. Taken to ER.
Patient called doctors' office, reported that after both doses of vaccine she did develop hives. Taking an antihistamine did help.
skin sensitivity; soreness; swelling; This is a spontaneous report from a contactable consumer and other health care professional (Patient). A 28-year-old non pregnant female patient received bnt162b2 (PFIZER BIONTECH COVID-19 Vaccine, Formulation: Solution for injection, Lot Number: ER8733) via an unspecified route of administration in left arm on 06Apr2021 at 02:15 PM (Age at vaccination 28-year) as dose 1, single for COVID-19 immunization. Medical history included obesity and known allergies of penicillin, both from an unknown date and unknown if ongoing. Concomitant medications included naproxen sodium (ALEVE); acetylsalicylic acid, caffeine, paracetamol (EXCEDRIN EXTRA STRENGTH); both taken for an unspecified indication, start and stop date were not reported. The patient previously took amoxicillin and experienced allergies. Reported facility type vaccine was hospital. Patient received other vaccine in four weeks. No COVID prior vaccination was reported; patient was not tested COVID post vaccination. On 06Apr2021 at 06:15 PM, the patient experienced skin sensitivity, soreness and swelling. Patient received no treatment for the adverse events. The clinical outcome of the events was resolved on an unspecified date in 2021.   No follow up attempts are possible. No further information is expected.
received the 1st dose in 2018 and is late for the 2nd; This case was reported by a pharmacist via call center representative and described the occurrence of incomplete course of vaccination in a female patient who received SHINGRIX. Previously administered products included SHINGRIX (received 1st dose in 2018 on an unknown date).   On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced incomplete course of vaccination. On an unknown date, the outcome of the incomplete course of vaccination was unknown.  Additional details were provided as follows: The age at vaccination was not applicable for this report. Till the time of reporting, the patient did not receive 2nd dose of Shingrix, which led to incomplete course of vaccination. The reporter consented to follow up.
This spontaneous report as received from a pharmacist refers to a 24 year old non-pregnant female patient. The patient had no pertinent medical history, no drug allergies/reactions and no concomitant therapy. On 22-FEB-2015 the patient was vaccinated with expired MMR II lot # H017027, expiry date 14-SEP-2014, 0.5 ml, subcutaneously, reason for vaccination: "needed for school". The patient developed "pinkish" color at the injection site after the vaccination. The outcome of the event was unknown. The relationship between the event and MMR II was not reported. Additional information has been requested.
A spontaneous consumer report received via regulatory authority (VAERS), concerns a 2 year old female patient. Her medical history and concurrent diseases were not reported. Concomitant medications were not reported. On 04-Oct-2012, the patient received FLUMIST (intranasal). Patient was admitted to hospital for symptoms of weakness and areflexia consistent for Guillain-Barre Syndrome which started on 06-Oct-2012. The outcome of the event of Guillain-Barre syndrome was unknown. Reporter assessed the Guillain-Barre syndrome to be serious as hospitalization.
Tongue and mouth swelling, tingling, throat itchy, cough, generalized itching, tachycardia, dizziness, hypotension, vomiting and diarrhea. Took albuterol, Zyrtec, Benadryl. Symptoms still ongoing. If worsening will go to ER
4 cm diameter area of warmth and erythema to right deltoid. 1.5 cm diameter area of warmth and erythema to left deltoid. No treatment. PPD negative.
By stander came into the office stating a mom with a child just receiving shots was in needing help. Mother reported within 5 minutes of vaccination she became unresponsive with muscle twitching, 911 called. Nurse responded within 40 sec. Nurse evaluation on arrival, eyes glazed, HR 54, BP 84/52 responsive to name, age and birth date within one minute. Ambulance took her to the ER.
Within a few hours of the vaccine I developed generalized muscle aches and pains. At approximately 12 hours I developed excruciating cramping pain in my ankles that moved to my thighs over a 2 hour period. I developed difficulty breathing and severe chest pain. I was admitted to the hospital for observation and discharged after receiving diagnostic testing and supportive care.  11/13/09 DS received for DOS 11/01/09  11/01/09 Final DX: Viral syndrome and chest pain.    The Pt was admitted to the hospital on 11/01/09 after 3 weeks HX of upper respiratory infection with nasal congestion and cough and 1 day after receiving H1N1 vaccine.  Pt reported developing difficulty breathing, severe chest pain, nausea, vomiting, general muscle cramping pain bilaterally in both ankles radiating to both calves, epigastric pain radiating to her left chest, left neck and left arm.  All the tests were negative and the Pt was discharged home in good condition.
Localized Muscle Pain; Headache; This is a spontaneous report from a contactable healthcare professional, the patient. A 34-year-old male patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6208) via an unspecified route of administration in the left arm on 14Mar2021 at 15:45 (at the age of 34-years-old) as a single dose for COVID-19 immunisation. The patient had no medical history. The patient had no known allergies to medications, food, or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient received unspecified medications within two weeks of vaccination. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 15Mar2021, the next day of vaccination, the patient experienced localized muscle pain and headache. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were taken as a result of the events localized muscle pain and headache which included treatment with ibuprofen (MANUFACTURER UNKNOWN). Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events localized muscle pain and headache was resolved on 15Mar2021.  No follow-up attempts are needed. No further information is expected.
shortness of breath; high heart rate; This is a spontaneous report from a contactable other healthcare professional (patient). A 29-year-old female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 VACCINE), administered in right arm on 04Mar2021 at 15:00 (at the age of 29-years-old) at 2nd dose, single for COVID-19 immunisation. The patient was not pregnant. Medical history was not reported. No COVID prior vaccination and no COVID tested post vaccination. Concomitant medications in two weeks included fluoxetine hydrochloride (PROZAC), propranolol. No other vaccine received in four weeks. The patient previously received the first dose of BNT162B2 on 11Feb2021 at 01:00 AM (at the age of 29-years-old) administered in the right arm for COVID-19 immunisation. The patient previously took codeine and experienced known allergies. The patient experienced high heart rate and shortness of breath on 04Mar2021 at 21:00. No treatment was received for the events. The outcome of the events was unknown.   No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Received High dose Flu Shot and second Pneumonia shot(both in one arm). 10 hours later, woke up with massive headache and when stood, body trembled violently. Took 1k mg's of TYLENOL and went back to bed. Arm was swollen from shot site to elbow, extremely hot and red. Stayed in bed next day, went to doctor following day. Doctor said nothing to do but take TYLENOL and BENADRYL and go back to pharmacist to let them known and make report.
PATIENT HAD SYNCOPE EPISODE UPON COMPLETION OF THIRD VACCINATION. PATIENT NEEDED Td, VARICELLA AND MMR COMPLETED FOR IMMIGRATION PROCESS. ADMINISTERED Td FIRST INTO RIGHT DELTOID THEN VARIVAX SECOND INTO RIGHT POSTERIOR SQ TISSUE THEN ADMINISTERED M-M-R II THIRD INTO LEFT POSTERIOR SQ TISSUE. UPON FINISHING INJECTION WHEN SYRINGE WAS TO AUTO RETRACT, PATIENT STATED SHE FELT FAINT AND STARTED TO LEAN TOWARDS HER RIGHT ONTO THE BENCH WE HAVE IN THE IMMUNIZATION ROOM. I GUIDED HER SLOWLY ONTO THE BENCH AND WHILE KEEPING ONE ARM ON HER SO SHE DIDN'T ROLL OFF THE BENCH, REACHED TO OPEN THE IMMUNIZATION DOOR TO HAVE MY TECHNICIAN CALL 9-1-1. PATIENT WAS UNCONSCIOUS FOR ABOUT TEN SECONDS AFTER WHICH TIME SHE STARTED TO HAVE INVOLUNTARY RAPID EYE MOVEMENTS WITH EYES OPENING THEN CRISS CROSSING. UPON STARTING TO AWAKEN, PATIENT BEGAN SPEAKING IN DIFFERENT LANGUAGE THEN ABOUT TEN SECONDS LATER SAT UP AS IF NOTHING HAPPENED. PARAMEDICS ARRIVED ON SCENE AND MEASURED BLOOD PRESSURE AND HOOKED UP A HEART MONITOR. BLOOD PRESSURE WAS LOW AT 80 PALP AND PULSE AT 46. PATIENT WAS TRANSPORTED TO HOSPITAL FOR EVALUATION.
Patient stated she felt her throat tightening and had trouble swallowing within 5 min or so of vaccination. History of shrimp anaphylaxis.
arm discoloration, mottling, redness after vaccine injected. No itching, urticaria, SOB, angioedema, nausea/vomiting. NO pain or discomfort. No additional complaints. Had similar reaction, but more severe to Sulfa drugs in the past. Given po Benadryl,  observed for additional 30 minutes prior to discharge
Started with soreness and swelling at injection site.  Progressed to Arthralgia.
Left arm (deltoid) red, swollen, hot to touch. Patient complained of numbness and tingling down arm with pain.
Pt walked in on 2/14/01 for a BP check and I observed a localized reaction to pt's left deltoid region where a TD (Adult) had been given on 2/5/01. Erythema and warmness noted at region measuring 3 1/2" X 2 1/2". Injection area was also itchy. Pt states reaction site was worse prior but not observed by us. Instructed to use OTC analgesics and antihistamines.
I broke out in hives all over my body, including my face, neck, arms, abdomen and legs.  The hives are still present, 2 weeks later.
On June 7th I had really bad diarrhea and the following 2 mornings I had no strength in my legs. I could not walk for at least 1/2 hour on June 7th and June 8th. I did not seek medical attention.
This spontaneous report was received from a 41 year old female registered nurse reporting on herself. No patient's pertinent medical history was reported. The patient's current condition and allergies included drug hypersensitivity to clindamycin, DARVOCET, KEFZOL and REGLAN. Concomitant therapies included EFFEXOR and sumatriptan succinate. On unknown dates in 1977, the patient was vaccinated with 2 doses of M-M-R II for routine vaccination and nursing school (strength, dose, dosage schedule, route, anatomical location, lot # and expiry date were not provided). Subsequently, on an unspecified date in approximately February 1995 (also reported as on February or March), the patient was found to have negative titers. Therefore, on unspecified dates in June and July 1995, the patient was vaccinated with a 2 doses of M-M-R II, respectively, for routine vaccination and nursing school (strength, dose, dosage schedule, route, anatomical location, lot # and expiry date were not provided). Later on 14-DEC-2018, the patient was found to have negative titers again. The outcome of antibody test negative was reported as not resolved. The reporter's causality assessment between M-M-R II with antibody test negative was not reported.
Chills; Fatigued; Arm red, swollen and feverish at the injection site; Arm red, swollen and feverish at the injection site; Feverish; This spontaneous case was reported by a consumer and describes the occurrence of CHILLS (Chills), FATIGUE (Fatigued), VACCINATION SITE ERYTHEMA (Arm red, swollen and feverish at the injection site), VACCINATION SITE SWELLING (Arm red, swollen and feverish at the injection site) and PYREXIA (Feverish) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 044B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 16-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 17-Apr-2021, the patient experienced CHILLS (Chills), FATIGUE (Fatigued), VACCINATION SITE ERYTHEMA (Arm red, swollen and feverish at the injection site), VACCINATION SITE SWELLING (Arm red, swollen and feverish at the injection site) and PYREXIA (Feverish). The patient was treated with PARACETAMOL (TYLENOL) for Adverse event, at an unspecified dose and frequency. On 18-Apr-2021, CHILLS (Chills) and FATIGUE (Fatigued) had resolved. At the time of the report, VACCINATION SITE ERYTHEMA (Arm red, swollen and feverish at the injection site), VACCINATION SITE SWELLING (Arm red, swollen and feverish at the injection site) and PYREXIA (Feverish) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were provided.
Headache, Myalgia, NauseaVomiting,  diaphoresis, fatigue, hip pain Narrative:
Swollen lymph nodes; This is a spontaneous report from a contactable consumer, the patient. A 26-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE;Lot Number: EP7534) via an unspecified route of administration in the arm right on 01Apr2021 at 15:15 (at the age of 26-years-old) as a single dose for COVID-19 immunisation. Medical history included hypertension. Concomitant medications included lisinopril (MANUFACTURER UNKNOWN) and amlodipine (MANUFACTURER UNKNOWN). The patient previously took flu shot and experienced minor outbreak of hives on his hands in 2016-17. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 03Apr2021 at 12:00, after 2685 minutes of the vaccination, the patient experienced swollen lymph nodes. The event did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the event. The clinical outcome of the event swollen lymph nodes was not resolved at the time of this report.   No follow-up attempts are needed. No further information is expected.
After completion of vaccinations patient slumped on exam table, and then began to convulse with eyes rolling in the back of his head.  His arms raised by his side and tightened.
Second dose given 21 days after 1st dose. Patient reports on 5/21/21 that she feels great and she has had no signs and symptoms to report other than a slight sore arm at the injection site lasting only for a few hours the first night.
Sick; Plaque psoriasis flare-up; This spontaneous case was reported by a patient and describes the occurrence of PSORIASIS (Plaque psoriasis flare-up) and ILLNESS (Sick) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.    Co-suspect product included non-company product ADALIMUMAB (HUMIRA) for Plaque psoriasis.    Concurrent medical conditions included Plaque psoriasis. On 03-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. In January 2022, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient started ADALIMUMAB (HUMIRA) (Subcutaneous) at an unspecified dose. On 01-May-2022, the patient experienced PSORIASIS (Plaque psoriasis flare-up). On an unknown date, the patient experienced ILLNESS (Sick). At the time of the report, PSORIASIS (Plaque psoriasis flare-up) outcome was unknown and ILLNESS (Sick) had resolved.      Concomitant products were not reported.  Moderna was reported 4782589. It was unknown if patient was enrolled in COVID-19-Vaccine Trial. Assessment results for Humira was provided Sickness, Non-Health Care Professional, Global Introspection, Possible and for Psoriasis aggravated, Non-Health Care Professional, Global Introspection, Not Related.  Treatment medications were not reported.
Sore arm; Very very low grade fever; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 66 year-old female patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose 2, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (DOSE 1, SINGLE), for COVID-19 immunization, reaction(s): "Sore arm". The following information was reported: PAIN IN EXTREMITY (non-serious), outcome "unknown", described as "Sore arm"; PYREXIA (non-serious), outcome "unknown", described as "Very very low grade fever". Additional Information: The patient has not received any other vaccine within 4 weeks prior to COVID vaccine.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202101465991 Same patient and drug, different events separated in time;US-PFIZER INC-202101465729 Same patient and drug, different events separated in time
Given flu shot and pneumonia shot in (L) arm 9/29. Sore right away and starting to swell by later that nite and esp by next day. By 2 days later red and swollen to 8.5 cm x 13 cm diameter. Very painful to move arm. No trouble breathing or other rash. Treated with ice packs, Ibuprofen, BENADRYL.
Child was given flu vaccine for 6months- to 35 months in error. There was no adverse reaction at this time
He tested positive for COVID-19 on 7/14/22. He had a cough and runny nose. His symptoms lasted for about 6 days. We contacted his doctor, but he did not prescribe medications. We treated him with over-the-counter medications and a humidifier.
Patient had redness, pain, and swelling at the site for 1 to 2 days. The redness, swelling, and itching has spread down the patients arm and hand. The affected area has become warm to the touch. Patient also reports insomnia since the redness and swelling has started. The patient was making a paste of Chlorpheniramine tablets and applying to area. On June 15th she took 1 Chlorpheniramine 4mg tablet orally. She was advised to contact her primary care provider and to take BENADRYL.
Patient presented to the ED and complained of bilateral posterior thigh and buttock pain. Reports the prior evening had cramping and a lump in left calf.
This case was reported by a nurse and described the occurrence of swelling in a 2 yr old male subject who was vaccinated with diphtheria and tetanus toxoids and acellular pertussis vaccine adsorbed (Infanrix) for prophylaxis. Concurrent medical conditions included eczema. On 29Aug05 the subject received a dose of Infanrix in the left arm (dose number not provided; lot AC14A006BA). On 29Aug05 the subject was also vaccinated with measles mumps and rubella virus vaccine (MMRII) and inactivated poliomyelitis virus vaccine (Ipol) at unspecified sites of administration. On 30Aug05, 1 day after vaccination with Infanrix, the subject experienced swelling down to the elbow and an injection site reaction characterized as redness, pain and warmth. The injection site reaction resolved on an unspecified date on or after 30Aug05 and on or before 06Sep05. The nurse considered the injection site reaction to probably be related to vaccination with Infanrix.
Pt exp onset 12 hrs post vax t103.5 ax, lt leg swollen thigh to knee & red & tender, not walking due to pain, vomiting; tx APAP, Phenergan, Advil, ice packs;
Lupus; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the parent.  A female patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose number unknown, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: SYSTEMIC LUPUS ERYTHEMATOSUS (non-serious), outcome "unknown", described as "Lupus".  The lot number for bnt162b2 was not provided and will be requested during follow up.
Immunized 70 Y/O female with Moderna vaccine Lot#010A21A. Client instructed to remain in observation area x 30 min. 11:42 client alert and oriented x 3. Noted to have flushed face & c/o SOB and chest tightening. Client reported she took OTC Benadryl 25MG. Reported allergies to iodine, shellfish, cipro and PCN. Abx caused rash. Current medications included Singular. 11:48 BP 162/110. Client continued to  experience SOB and chest tightening. Called 911 & activated EMS. Continued to observe client. 11:56 EMS arrived and completed an assessment. BP 171/97 -87. Client reported she was feeling better. 12:10 Client refused EMS transport. 12:20 client drove home. 3:07 called client for follow up. She stated she felt better but tired and had a HA.
The patient received Moderna vaccine on 12/4/2021. Approximately 1-2 minutes after the injection, the patient reported dizziness and had pale skin. The patient denied chest pain, SOB. The patient was monitored for an additional 30 minutes post reaction.  Vitals were stable.  Apple juice, crackers, cold compress given.  Patient was stable when discharged.  Instructions were given to notify their PCP of this incident.